Remove Arcturus Remove Blogging Remove Development Remove Funding
article thumbnail

RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug

Xconomy

San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be broadly used to treat cystic fibrosis patients. Arcturus says its technology can be used to make.

article thumbnail

Arcturus Board Sues Ex-CEO, Alleges Deceit, in Prelude to Proxy Fight

Xconomy

The board that fired Arcturus Therapeutics co-founder and CEO Joseph E. Payne earlier this year unleashed a new broadside this week in the ongoing battle for control of the San Diego-based RNA drug developer. Payne, who. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.